UBS Group
BSEM icon

UBS Group’s BioStem Technologies BSEM Stock Holding History

UBS Group’s Portfolio BSEM Stock Details BSEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$61.7K Buy
+19,969
New +$75.9K ﹤0.01% 7493

Other funds holding BSEM

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Ashton Thomas Private Wealth
Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Atlantic Union Bankshares
Atlantic Union Bankshares Glen Allen, Virginia $6.11B AUM 17.62% 1-Year Est. Return
Gables Capital Management
Gables Capital Management Miami, Florida $267M AUM 34.53% 1-Year Est. Return
Wolff Wiese Magana
Wolff Wiese Magana Carslbad, California $218M AUM 37.48% 1-Year Est. Return
Birchbrook
Birchbrook Bangor, Maine $209M AUM 12.33% 1-Year Est. Return
Global Retirement Partners
Global Retirement Partners San Rafael, California $7.1B AUM

UBS Group's BSEM Position: Q3 2026 in Review

UBS Group opened a new position in BioStem Technologies (BSEM) in Q3 2026: 19,969 shares worth $61.7K. The stake represents ﹤0.01% of the portfolio and ranks #7493 among its holdings.

13 funds tracked by Wall St. Rank hold BSEM as of Q3 2026.

  • UBS Group held 19,969 shares of BioStem Technologies worth $61.7K as of Q3 2026.
  • BioStem Technologies was a new UBS Group position in Q3 2026.
  • BioStem Technologies made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7493 holding.
  • 13 funds tracked by Wall St. Rank held BioStem Technologies as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.